Cancer Family
Musculoskeletal Neoplasm
CI-CAN-00000278Explore in graph →
Non-malignant212 active trials5 approved drugs54 evidence items
- NCIt
- C166354
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000278Explore in graph →
Clinical trials
1,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03989661 | Is There a Place for Pre-operative Temporary Embolization of Uterine Fibroids(EMBOFIB) | completed | — | 119 | Fondation Hôpital Saint-JosephOTHER | 1 | Apr 27, 2023 | clinicaltrials |
| NCT03927651 | ICG to Assess Ovarian Perfusion | completed | Early Phase 1 | 54 | Northwestern UniversityOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05110430 | Automated Detection of Metastatic Bone Disease on Bone Scintigraphy Scans | completed | — | 2,365 | Maastricht UniversityOTHER | 1 | Mar 20, 2023 | clinicaltrials |
| NCT05732558 | Augmented Reality Navigation System (Endosight) for the Guidance of Bone Biopsy | completed | N/A | 16 | R.A.W. - S.R.L.INDUSTRY | 1 | Mar 9, 2023 | clinicaltrials |
| NCT04844697 | Resilience and Coping in a Rare Skeletal Disease Population to Face Coronavirus (COVID-19) Outbreak Distress: a Longitudinal Study(RELOAD) | completed | — | 15 | Istituto Ortopedico RizzoliOTHER | 1 | Mar 1, 2023 | clinicaltrials |
| NCT03985449 | Implementation of Uterine Fibroid Option Grid Patient Decision Aids Across Five Organizational Settings(UPFRONT) | completed | N/A | 748 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Feb 28, 2023 | clinicaltrials |
| NCT02890758 | Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 | completed | Phase 1 | 14 | Brenda Cooper, MDOTHER | 1 | Feb 21, 2023 | clinicaltrials |
| NCT04956198 | Drug Sensitivity and Mutation Profiling | completed | — | 14 | Florida International UniversityOTHER | 1 | Feb 14, 2023 | clinicaltrials |
| NCT03655587 | Impact of an Orthotic Intervention in Children With Peripheral Neuropathy(IOPN) | completed | N/A | 27 | Children's Hospitals and Clinics of MinnesotaOTHER | 1 | Feb 10, 2023 | clinicaltrials |
| NCT01563783 | Post Market TRUST Study(TRUST) | completed | N/A | 84 | Acessa Health, Inc.INDUSTRY | 1 | Feb 1, 2023 | clinicaltrials |
| NCT00354835 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma | completed | Phase 3 | 481 | Children's Oncology GroupNETWORK | 6 | Jan 31, 2023 | clinicaltrials |
| NCT03972917 | Observation of Long-term Effects on Endometrium and Uterine Fibroids in Women With Ulipristal Acetate Therapy | completed | — | 89 | University of Campania Luigi VanvitelliOTHER | 1 | Jan 18, 2023 | clinicaltrials |
| NCT05643339 | The Reproducibility of Microvascular Flow Imaging in Fibroids and Its Correlation With 2D and 3D Power Doppler Outcomes(MVF) | completed | — | 30 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Dec 8, 2022 | clinicaltrials |
| NCT00396279 | Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone | completed | Phase 2 | 37 | AmgenINDUSTRY | 0 | Nov 8, 2022 | clinicaltrials |
| NCT03389724 | Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia | completed | Phase 3 | 245 | Children's Cancer Hospital Egypt 57357OTHER | 1 | Nov 8, 2022 | clinicaltrials |
| NCT02620748 | Use of Intravenous Tranexamic Acid During Myomectomy(TA) | completed | Phase 1 | 60 | George Washington UniversityOTHER | 1 | Oct 13, 2022 | clinicaltrials |
| NCT00680992 | Study of Denosumab in Subjects With Giant Cell Tumor of Bone | completed | Phase 2 | 535 | AmgenINDUSTRY | 12 | Sep 22, 2022 | clinicaltrials |
| NCT05475938 | Application of Painting Analysis and Psychotherapy in Children With Bone Tumors | completed | N/A | 40 | Henan Cancer HospitalOTHER_GOV | 1 | Jul 29, 2022 | clinicaltrials |
| NCT03245450 | Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors | completed | Phase 1 / Phase 2 | 40 | Eisai Inc.INDUSTRY | 8 | Jun 28, 2022 | clinicaltrials |
| NCT05419414 | The Use of Shear Wave Elastography, Transvaginal Ultrasound and Pelvic MRI in the Diagnosis of Adenomyosis | completed | N/A | 65 | Istanbul UniversityOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT05402865 | A Real-world Study on Patients of Unresectable Giant Cell Tumor of Bone | completed | — | 301 | Shanghai JMT-Bio Inc.INDUSTRY | 1 | Jun 2, 2022 | clinicaltrials |
| NCT00474448 | The Health-Related Quality of Life in Patients With Hereditary Multiple Exostoses | completed | — | 200 | University of British ColumbiaOTHER | 1 | May 18, 2022 | clinicaltrials |
| NCT00346164 | Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma | completed | Phase 3 | 588 | Children's Oncology GroupNETWORK | 5 | Apr 28, 2022 | clinicaltrials |
| NCT02821507 | Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma | completed | Phase 2 | 70 | Leiden University Medical CenterOTHER | 2 | Apr 20, 2022 | clinicaltrials |
| NCT03103087 | LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids | completed | Phase 3 | 382 | Myovant Sciences GmbHINDUSTRY | 8 | Apr 20, 2022 | clinicaltrials |
| NCT03049735 | LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids | completed | Phase 3 | 388 | Myovant Sciences GmbHINDUSTRY | 6 | Apr 19, 2022 | clinicaltrials |
| NCT02239861 | TAA-Specific CTLS for Solid Tumors (TACTASOM) | completed | Phase 1 | 16 | Baylor College of MedicineOTHER | 1 | Apr 12, 2022 | clinicaltrials |
| NCT02050919 | Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma | completed | Phase 2 | 20 | OHSU Knight Cancer InstituteOTHER | 1 | Mar 21, 2022 | clinicaltrials |
| NCT02349971 | Safety and Feasibility of MR-Guided High Intensity Focused Ultrasound (MR-HIFU) Ablation of Osteoid Osteoma in Children | completed | N/A | 9 | Children's National Research InstituteOTHER | 1 | Mar 11, 2022 | clinicaltrials |
| NCT02982941 | Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors | completed | Phase 1 | 25 | MacroGenicsINDUSTRY | 1 | Feb 8, 2022 | clinicaltrials |
| NCT02737553 | Laparoscopic Enclosed Morcellation; Electromechanic Morcellation vs Vaginal Removal | completed | N/A | 118 | Ege UniversityOTHER | 1 | Jan 24, 2022 | clinicaltrials |
| NCT02452554 | Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma | completed | Phase 2 | 62 | Children's Oncology GroupNETWORK | 1 | Jan 13, 2022 | clinicaltrials |
| NCT05182853 | Voiding Disorders in Children After Sacrococcygeal Teratoma Resection(TSC-URO) | completed | — | 8 | University Hospital, MontpellierOTHER | 1 | Jan 11, 2022 | clinicaltrials |
| NCT04911972 | Functional Muscle Transfers in Lower Limb Sarcoma: 3D Gait Analysis and Environmental Simulation | completed | — | 27 | NHS Greater Glasgow and ClydeOTHER | 1 | Dec 13, 2021 | clinicaltrials |
| NCT03317795 | Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids | completed | Phase 4 | 18 | Shannon K. Laughlin-TommasoOTHER | 1 | Dec 8, 2021 | clinicaltrials |
| NCT02323295 | Effect of High Doses of Radiation on Bone Structure and Metabolism | completed | N/A | 12 | Massachusetts General HospitalOTHER | 1 | Dec 7, 2021 | clinicaltrials |
| NCT00075582 | Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma | completed | Phase 3 | 390 | Children's Oncology GroupNETWORK | 6 | Nov 19, 2021 | clinicaltrials |
| NCT03284320 | Retrospective Study in Sarcoma Patients(ReTraSarc) | completed | — | 514 | University Medicine GreifswaldOTHER | 1 | Nov 15, 2021 | clinicaltrials |
| NCT04030182 | Vitamin D Deficit in Women With Uterine Fibroids | completed | — | 127 | Instituto Mexicano del Seguro SocialOTHER_GOV | 1 | Nov 8, 2021 | clinicaltrials |
| NCT02247544 | Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma(TRAVELL) | completed | Phase 2 | 105 | Italian Sarcoma GroupNETWORK | 1 | Nov 1, 2021 | clinicaltrials |
| NCT04672421 | The Efficacy and Safety of Medicurtain® in Patients With Total Laparoscopic Hysterectomy (Pivotal Study) | completed | N/A | 107 | Shin Poong Pharmaceutical Co. Ltd.INDUSTRY | 1 | Sep 29, 2021 | clinicaltrials |
| NCT01532687 | Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma | completed | Phase 2 | 54 | OHSU Knight Cancer InstituteOTHER | 1 | Sep 27, 2021 | clinicaltrials |
| NCT04819633 | Evaluating Serum Sestrin in Leiomyoma Patients | completed | — | 61 | Sisli Hamidiye Etfal Training and Research HospitalOTHER | 1 | Sep 21, 2021 | clinicaltrials |
| NCT03768076 | an Istitution Experience on Parosteal OsTeosarcoma | completed | — | 220 | Istituto Ortopedico RizzoliOTHER | 1 | Aug 5, 2021 | clinicaltrials |
| NCT04983719 | Transcervical Myoma Biopsy Video(TMBV) | completed | — | 1 | University Hospital, MontpellierOTHER | 1 | Jul 30, 2021 | clinicaltrials |
| NCT04660591 | Length of the Femoral Stem in Arthroplasty Done for Patients With Proximal Femoral Metastatic Lesion | completed | N/A | 24 | Ain Shams UniversityOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT00731341 | Hysteroscopic Cryomyolysis for the Treatment of Submucosal Leiomyomata | completed | N/A | 3 | Boston Scientific CorporationINDUSTRY | 1 | Jul 19, 2021 | clinicaltrials |
| NCT01441635 | Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids | completed | Phase 2 | 271 | AbbVie (prior sponsor, Abbott)INDUSTRY | 0 | Jul 13, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Apr 27, 2023source: clinicaltrials